Incyte INCY
NASDAQ INCY
$127.85 -0.15 (-0.12%)
As of: Sep 4, 2026 · 2:42 PM EDT

Incyte (INCY) Interest & Investment Income (2010 - 2026)

Incyte's (INCY) quarterly Interest & Investment Income came in at $38.1 million in Q2 2026, up 51.65% YoY from $25.1 million in Q2 2025, and up 13.15% on a QoQ basis from $33.7 million in Q1 2026.

Analysis

Incyte (INCY) Interest & Investment Income (2010 - 2026) Analysis & Trends

Incyte (INCY) has 11 years of Interest & Investment Income data on file, last reported at $38.1 million in Q2 2026.

  • Quarterly Interest & Investment Income rose 51.65% year-over-year to $38.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $129.3 million (up 46.1% YoY) and the FY2025 annual result came in at $105.6 million, down 17.96% from the prior year.
  • Interest & Investment Income rose to $38.1 million in Q2 2026, from $33.7 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $46.8 million in Q1 2024 to a low of $19.3 million in Q3 2024.
  • A 3-year average of $30.6 million and a median of $28.8 million in 2025 frame the typical range for Interest & Investment Income.
  • Annual changes were most pronounced in 2025 — Interest & Investment Income slumped 50.97% — and 2026, when it soared 51.65%.
  • Tracing INCY's Interest & Investment Income over 3 years: stood at $21.2 million in 2024, then surged by 45.08% to $30.8 million in 2025, then increased by 23.94% to $38.1 million in 2026.
  • The last three Interest & Investment Income figures came in at $38.1 million (Q2 2026), $33.7 million (Q1 2026), and $30.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.80 Bn 130.95 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.54 Bn 77.55 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.07 Bn 52.93 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.01 Bn 44.01 Bn - 35.58 Mn
6 BeOne Medicines 39.98 Bn 34.88 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.40 Bn 32.09 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.40 Bn 27.57 Bn - 5.13 Mn
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn 10.98 Mn
10 Incyte 25.62 Bn 21.08 Bn 1.57 Bn 38.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38.12 Mn
Mar 31, 2026 33.69 Mn
Dec 31, 2025 30.75 Mn
Sep 30, 2025 26.78 Mn
Jun 30, 2025 25.14 Mn
Mar 31, 2025 22.93 Mn
Dec 31, 2024 21.20 Mn
Sep 30, 2024 19.27 Mn
Jun 30, 2024 41.48 Mn
Mar 31, 2024 46.77 Mn
Dec 31, 2017 6.27 Mn
Sep 30, 2017 5.56 Mn
Jun 30, 2017 4.13 Mn
Mar 31, 2017 1.20 Mn
Dec 31, 2016 594,000.00
Sep 30, 2016 1.19 Mn
Jun 30, 2016 1.14 Mn
Mar 31, 2016 1.49 Mn
Dec 31, 2015 1.29 Mn
Sep 30, 2015 3.03 Mn